Beacon Biosignals announced that it has acquired Snap Diagnostics, a premier home sleep testing (HST) provider serving patients in all 50 states. The acquisition more than doubles Beacon’s patient reach, making it one of the largest HST providers in the United States and establishing a national channel to bring EEG-enabled […]

We’re happy to announce that we’ve received our Phase I Small Business Innovation Research (SBIR) award from the National Institutes of Health, through the National Heart, Lung, and Blood Institute (NHLBI). This award supports real-world testing of our in-ear sensor system for in-lab and ambulatory sleep monitoring, along with the […]

HoneyNaps, specializing in AI-powered sleep medical devices, has developed a next-generation wireless polysomnography system that combines patch-based skin sensors with artificial intelligence-driven analysis. Polysomnography (PSG) is the standard diagnostic test for sleep disorders such as sleep apnea. Conventional PSG, however, generally requires patients to spend a night at a hospital […]

A short workout or a nap can help protect memory after a sleepless night, a McGill University-led study has found. Researchers found people who either completed 20 minutes of moderate-to-vigorous exercise or took a 90-minute nap performed about 22 per cent better on memory tests after 30 hours without sleep […]

An analysis of biological clocks throughout the human body suggests that too few hours of sleep—and too many—may speed aging in the brain, heart, lung, and immune system and is associated with a wide range of diseases. “Previous studies have found that sleep is largely linked to aging and the […]

With more than 7 million Americans living with Alzheimer’s dementia — a number projected to reach nearly 13 million by 2050 — new Emory University research suggests that higher vitamin D supplement intake may be associated with better cognitive function in adults with an elevated risk of dementia. In a […]

Alkermes plc announced plans to present two oral presentations and six posters from its industry-leading portfolio of sleep medicine research at the European Sleep Research Society’s (ESRS) 28th Congress, Sleep Europe 2026, taking place Oct. 20-23, 2026 in Maastricht, the Netherlands. The company will present new data related to LUMRYZ® […]

Takeda announced that ORZEYFUL (oveporexton) is now available in Japan and China for the treatment of narcolepsy type 1 (NT1), providing first access to clinicians to prescribe treatment with the new class of medicine. ORZEYFUL is a first-in-class orexin receptor 2 (OX2R) agonist, in tablet form, designed to treat the […]

Mosanna Therapeutics, Inc., announced results from its Phase 1 MOSAIC study. MOS118 was safe and well tolerated across all doses, with no serious adverse events reported. These results support progression of the study into patients with OSA. “With these results we can now proceed to evaluate MOS118 in the patients it […]

Home sleep testing has come a long way over the past decade. The industry has moved beyond simply asking whether a patient can be…

In 1974, President Nixon launched a bold strategy to address the U.S. Oil Crisis. The thinking was that if Daylight Saving Time…

Over the past 15 years, I have watched sleep medicine evolve through a number of transformative cycles—from lab-dominant…

ProSomnus Sleep Technologies announced the formation of its inaugural Medical Advisory Board, significant enhancements to its…

Panthera Dental announced a $13 million investment to expand its head office by 20,000 square feet, bringing the total size to…

Patients diagnosed with a temporomandibular disorder (TMD) are at increased risk for obstructive sleep apnea (OSA) compared to…